April 2026 Issue is Now Live!

Features

A Cover Story of Medical Device Surface Treatments & Coatings

Nearly a dozen surface treatment and coatings experts discuss their business trends and challenges for medical device manufacturing.

SPONSOR

Beyond PFAS: How Zeus’ PFX™ Platform Expands Possibilities for Catheter Design

Zeus CTO Suresh Sainath explains how the PFX™ platform delivers high-performance catheter materials while opening new possibilities beyond fluoropolymers.

Features

The Petite Passageways of Medical Device Tubing

New innovations to treat myriad conditions require tubing with thinner walls and smaller profiles while providing kink resistance and strength.

Features

Nerve Agents: A Look at the Neurostimulation Device Market

Miniaturization, power efficiency, and less invasive, personalized therapies are shaping current neurostimulation solutions.

SPONSOR

Leveraging Manufacturability and Coatings for Medtech Solutions

Working with a partner that has capabilities in coating technologies and manufacturing services can add greater value for a medtech project.

Medtech Musings

Cell Implant Device Could Control Type 1 Diabetes

MIT researchers are building an implantable device that contains insulin-producing cells, also known as islet cells.

Dollars & $ense

How Medtech Companies Can Maximize the R&D Tax Credit

With engineering investment both continuous and capital-intensive, this incentive can meaningfully offset development costs.

Cybersecurity

Questioning the Continued Lack of a Focus on Cybersecurity

It's similar to dealing with a medical insurance provider: “Deny, Delay, Defund.”

Software Solutions

The 2026 Medtech Regulatory Surge Makes Technology Architecture a Board-Level Decision

Beyond just an IT concern, enterprise architecture now defines how companies navigate changing regulations and build towards future innovation.

C-Suite Reflections

The AI Valuation Gap at Exit: Why Medtech Companies Should Not Ignore AI

The buyers who will set valuations are already asking AI-specific questions during initial conversations.

From the Bench

The Right Test, Not More Tests: Rethinking Biocompatibility Strategy

Biocompatibility is a safety story, and regulators expect the evidence to support every chapter.

Datawatch

The Selective Capex Comeback: Medtech Capital Sales in 2026

2026 finds medtech capital equipment sales in a disciplined, selective capex upcycle.

Regulatory Perspectives

Why Disconnected QMS and RIMS Are a Significant Commercial Risk

The number of potential gaps could surprise many medtech manufacturers who seriously examine the disparity between QMS and RIMS.

Design Viewpoint

3 Engineering Barriers to Prevent Dendrite Growth in Implantable Electronics

In the body’s warm, saline conditions, small metal ions can slowly create conductive filaments between circuit routes.

Columns

Why Measuring Laser Performance Is Vital for Micromachining

Even the most advanced laser systems are only as reliable as the measurements used to monitor their performance.

Editor's Letter

My Day Under the (Surgical) Lights

The “benefit” of observing a hospital from the patient perspective.

Solution Content Centers SPOTLIGHT

Confluent Medical Technologies

Confluent Medical Technologies applies materials science to MedTech innovation. Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Our key capabilities include Nitinol components and material, balloons and balloon catheters, complex catheters and components, high-precision polymer tubing, and implantable textiles.